山东东方海洋科技股份有限公司2025年半年度报告摘要

Core Viewpoint - The company, Shandong Oriental Ocean Technology Co., Ltd., has released its 2025 semi-annual report, which reflects its operational results, financial status, and future development plans. The report indicates that there will be no cash dividends or stock bonuses distributed to shareholders during this period [3][4][5]. Company Overview - The company has confirmed that there have been no changes in its controlling shareholder or actual controller during the reporting period [5][6]. - The board of directors and the supervisory board have both approved the semi-annual report, affirming that the report complies with legal and regulatory requirements and accurately reflects the company's situation [9][16]. Financial Data and Indicators - The semi-annual report includes key financial data and indicators, although specific figures are not detailed in the provided documents [4]. Important Events - The company’s wholly-owned subsidiary, Aiveke Biotechnology Co., Ltd., has obtained a medical device registration certificate for its serum amyloid A (SAA) testing kit, which is expected to enhance its product line in clinical testing [12][14]. - The impact of this new product on the company's performance is currently uncertain, as it has not yet commenced production and its sales will depend on market demand and expansion efforts [13][14].